Estrogen Receptor Signaling in Lung Cancer

This publication has 71 references indexed in Scilit:

• Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
  The Lancet, 2009
• Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 2009
• Estrogen Receptor β as a Mitochondrial Vulnerability Factor
  Journal of Biological Chemistry, 2009
• Estrogenic control of mitochondrial function and biogenesis
  Journal of Cellular Biochemistry, 2008
• Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer
  Lung Cancer, 2008
• Estrogen actions on mitochondria—Physiological and pathological implications
  Molecular and Cellular Endocrinology, 2008
• Lung dysfunction causes systemic hypoxia in estrogen receptor β knockout (ERβ ^−/− ) mice
  Proceedings of the National Academy of Sciences, 2006
• A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
  New England Journal of Medicine, 2004
• ERβ: Identification and characterization of a novel human estrogen receptor
  FEBS Letters, 1996
• Cloning of a novel receptor expressed in rat prostate and ovary.
  Proceedings of the National Academy of Sciences, 1996